• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR-UTAH SYNCHRO 2/14 300 CM STANDARD; WIRE, GUIDE, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR-UTAH SYNCHRO 2/14 300 CM STANDARD; WIRE, GUIDE, CATHETER Back to Search Results
Catalog Number M00326510
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemorrhage, Cerebral (1889); Vascular Dissection (3160)
Event Date 01/18/2017
Event Type  Injury  
Manufacturer Narrative
The device is not available to the manufacturer.
 
Event Description
It was reported that a procedure had taken place to implant a flow diverter in a wide-necked aneurysm at the level of the medium cerebral artery.The patient was pre-treated with aspirin, plavix, a vasodilator to prevent arteries spasm and with a double anti-aggregation therapy.Catheterization of the vessel was performed with the microcatheter , distal access catheter and a guidewire (subject device).The patient had a complex anatomy and the three devices were placed in the distal (m3) in order to obtain the necessary support to stretch the micro catheter and to have a normal aspect in the middle cerebral artery.A distal dissection occured when the microcatheter and guidewire (subject device) were being placed in the m3 leading to cerebral hemorrhage in the left m3.The hemorrhage was stopped by implanting three coils and some ml of onyx through the microcatheter.The procedure was terminated without treating the aneurysm and a scan at the end of the procedure showed a hematoma in the middle cerebral artery.New platelets were injected to reverse the effects of the double anti-aggregation therapy given at the beginning of the procedure.A second scan confirmed that the hematoma was increasing and a decompressive craniotomy was performed later in the evening in attempt to diffuse the hematoma.A third scan showed regression of the mass effect, the ventricle was a normal size and intracranial pressure stabilized as well.The patient remains hospitalized in stable condition.No further information is available.
 
Manufacturer Narrative
The device history record review confirms that the device met all material, assembly and performance specifications.The subject device was not available; therefore, a visual inspection as well as a functional evaluation could not be performed.Cerebral hemorrhage, hematoma and dissection are known risks associated with endovascular procedures and are noted as such in the device directions for use (dfu); therefore, anticipated in nature.However, because the device was not returned the exact cause for the difficulties encountered with the device cannot be definitively determined.
 
Event Description
It was reported that a procedure had taken place to implant a flow diverter in a wide-necked aneurysm at the level of the medium cerebral artery.The patient was pre-treated with aspirin, plavix, a vasodilator to prevent arteries spasm and with a double anti-aggregation therapy.Catheterization of the vessel was performed with the microcatheter , distal access catheter and a guidewire (subject device).The patient had a complex anatomy and the three devices were placed in the distal (m3) in order to obtain the necessary support to stretch the micro catheter and to have a normal aspect in the middle cerebral artery.A distal dissection occured when the microcatheter and guidewire (subject device) were being placed in the m3 leading to cerebral hemorrhage in the left m3.The hemorrhage was stopped by implanting three coils and some ml of onyx through the microcatheter.The procedure was terminated without treating the aneurysm and a scan at the end of the procedure showed a hematoma in the middle cerebral artery.New platelets were injected to reverse the effects of the double anti-aggregation therapy given at the beginning of the procedure.A second scan confirmed that the hematoma was increasing and a decompressive craniotomy was performed later in the evening in attempt to diffuse the hematoma.A third scan showed regression of the mass effect, the ventricle was a normal size and intracranial pressure stabilized as well.The patient remains hospitalized in stable condition.No further information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHRO 2/14 300 CM STANDARD
Type of Device
WIRE, GUIDE, CATHETER
Manufacturer (Section D)
STRYKER NEUROVASCULAR-UTAH
2405 orion circle
west valley city UT 84119
Manufacturer (Section G)
STRYKER NEUROVASCULAR-UTAH
2405 orion circle
west valley city UT 84119
Manufacturer Contact
michael reddick
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key6289971
MDR Text Key66164264
Report Number3008880413-2017-00004
Device Sequence Number1
Product Code DQX
UDI-Device Identifier04546540688781
UDI-Public(01)04546540688781(17)190731(10)B42505
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K053268
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/25/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/31/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2019
Device Catalogue NumberM00326510
Device Lot NumberB42505
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/15/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AXS DISTAL ACCESS CATHETER (STRYKER); XT-17 MICROCATHETER (STRYKER)
Patient Outcome(s) Other; Required Intervention;
Patient Age71 YR
-
-